BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders... Show more
BWAY's Aroon Indicator triggered a bullish signal on September 12, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 202 similar instances where the Aroon Indicator showed a similar pattern. In of the 202 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on August 08, 2025. You may want to consider a long position or call options on BWAY as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
BWAY moved above its 50-day moving average on August 11, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BWAY crossed bullishly above the 50-day moving average on August 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for BWAY moved out of overbought territory on September 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Moving Average Convergence Divergence Histogram (MACD) for BWAY turned negative on September 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .
BWAY broke above its upper Bollinger Band on August 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.191) is normal, around the industry mean (60.236). P/E Ratio (53.911) is within average values for comparable stocks, (38.113). BWAY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.622). BWAY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (6.447) is also within normal values, averaging (80.051).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a developer and manufacturer of deep transcranial magnetic stimluation systems, novel, noninvasive medical devices
Industry MedicalNursingServices
A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with STIM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then STIM could also see price increases.
Ticker / NAME | Correlation To BWAY | 1D Price Change % | ||
---|---|---|---|---|
BWAY | 100% | +0.41% | ||
STIM - BWAY | 34% Loosely correlated | -9.68% | ||
CLPT - BWAY | 34% Loosely correlated | -5.41% | ||
BFLY - BWAY | 32% Poorly correlated | +1.29% | ||
ISRG - BWAY | 31% Poorly correlated | -1.35% | ||
ARAY - BWAY | 30% Poorly correlated | -1.26% | ||
More |
Ticker / NAME | Correlation To BWAY | 1D Price Change % |
---|---|---|
BWAY | 100% | +0.41% |
Medical/Nursing Services industry (225 stocks) | 33% Loosely correlated | +1.06% |
Health Services industry (437 stocks) | 26% Poorly correlated | +0.42% |